Trials / Completed
CompletedNCT03928470
Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg
A Multicenter, Randomized, Double-blind, Active-controlled Phase 4 Study to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg in Patients With Non-erosive Reflux Disease(NERD)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 379 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
To Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg
Detailed description
A multicenter, randomized, double-blind, active-controlled phase 4 study to evaluate the efficacy and safety of EsoDuo Tab. 20/800mg in patients with non-erosive reflux disease(NERD)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EsoDuo Tab. 20/800mg | Nexium Tab. 20mg |
Timeline
- Start date
- 2019-01-29
- Primary completion
- 2019-12-20
- Completion
- 2019-12-20
- First posted
- 2019-04-26
- Last updated
- 2019-12-24
Locations
38 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03928470. Inclusion in this directory is not an endorsement.